SLC5A2 and type 2 diabetes mellitus: Additionally, SGLT2 inhibitors attenuated pTau accumulation by modulating brain insulin signaling through the angiotensin-converting enzyme 2/angiotensin (1–7)/mitochondrial assembly receptor axis in a T2D-AD mouse model (170).